
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Ganglioneuroma staging
Introduction
Overview
Overview
According to the International Neuroblastoma Staging System (INSS), there are six stages of ganglioneuroma based on clinical, radiologic, and surgical features.[1]
Staging
Staging
According to the International Neuroblastoma Staging System (INSS), there are six stages of ganglioneuroma based on clinical, radiologic, and surgical features.[1]
Stage 1
- Localized tumor confined to the area of origin
- Complete gross excision, with or without microscopically residual disease
- Identifiable ipsilateral and contralateral lymph node negative microscopically
Stage 2A
- Unilateral tumor with incomplete gross excision
- Identifiable ipsilateral nonadherent lymph node negative microscopically
Stage 2B
- Unilateral tumor with complete or incomplete gross excision
- Positive ipsilateral nonadherent lymph nodes
- Identifiable contralateral lymph node negtive microscopically
Stage 3
- Tumor infiltrating across the midline (vertebral column) with or without regional lymph node involvement
- OR
- Unilateral tumor with contralateral regional lymph node involvement
- OR
- Midline tumor with bilateral regional lymph node involvement or extension by infiltration
Stage 4
- Dissemination of tumor to distant lymph nodes, bone, bone marrow, liver or other organs (except as defined in stage 4S)
Stage 4S
- Localized primary tumor as defined for stage 1 or 2 with dissemination limited to liver, skin, and/or bone marrow (<10% tumor) in infants younger than 1 yr
References
References
- ↑ 1.0 1.1 Adam, O; Boia, ES (2007). “ganglioneuroma” (PDF). jurnalul pediatrului. 10 (39–40). Retrieved 10 September 2015.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
